{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:43:12Z","timestamp":1793248992609,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vitamin K plays a crucial role in the regulation of vascular calcifications by allowing activation of matrix Gla protein. The dietary requirement for vitamin K is low because of an efficient recycling of vitamin K by vitamin K epoxide reductase (VKORC1). However, decreased VKORC1 activity may result in vascular calcification. More than 30 coding mutations of <jats:italic>VKORC1<\/jats:italic> have been described. While these mutations have been suspected of causing anticoagulant resistance, their association with an increase in the risk of vascular calcification has never been considered. We thus investigated functional cardiovascular characteristics in a rat model mutated in <jats:italic>VKORC1<\/jats:italic>. This study revealed that limited intake in vitamin K in mutated rat induced massive calcified areas in the media of arteries of lung, aortic arch, kidneys and testis. Development of calcifications could be inhibited by vitamin K supplementation. In calcified areas, inactive Matrix Gla protein expression increased, while corresponding mRNA expression was not modified. Mutation in <jats:italic>VKORC1<\/jats:italic> associated with a limited vitamin K intake is thus a major risk for cardiovascular disease. Our model is the first non-invasive rat model that shows spontaneous medial calcifications and would be useful for studying physiological function of vitamin K.<\/jats:p>","DOI":"10.1038\/s41598-018-31788-6","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T09:31:28Z","timestamp":1536312688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Missense mutation of VKORC1 leads to medial arterial calcification in rats"],"prefix":"10.1038","volume":"8","author":[{"given":"Arnaud","family":"Michaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Matagrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Val\u00e9ry","family":"Debaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-6957","authenticated-orcid":false,"given":"Leon J.","family":"Schurgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lattard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"31788_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tcm.2014.10.021","volume":"25","author":"JA Leopold","year":"2015","unstructured":"Leopold, J. A. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc. Med. 25, 267\u2013274 (2015).","journal-title":"Trends Cardiovasc. Med."},{"key":"31788_CR2","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1182\/blood-2006-08-040709","volume":"109","author":"LJ Schurgers","year":"2007","unstructured":"Schurgers, L. J. et al. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109, 2823\u20132831 (2007).","journal-title":"Blood"},{"key":"31788_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/ATVBAHA.114.304823","volume":"35","author":"CSB Viegas","year":"2015","unstructured":"Viegas, C. S. B. et al. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Arterioscler. Thromb. Vasc. Biol. 35, 399\u2013408 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"31788_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"G Luo","year":"1997","unstructured":"Luo, G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78\u201381 (1997).","journal-title":"Nature"},{"key":"31788_CR5","first-page":"182","volume":"3","author":"MJ Shearer","year":"2012","unstructured":"Shearer, M. J., Fu, X. & Booth, S. L. Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv. Nutr. Bethesda Md 3, 182\u2013195 (2012).","journal-title":"Bethesda Md"},{"key":"31788_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5482\/ha-1157","volume":"31","author":"MLL Chatrou","year":"2011","unstructured":"Chatrou, M. L. L., Reutelingsperger, C. P. & Schurgers, L. J. Role of vitamin K-dependent proteins in the arterial vessel wall. Hamostaseologie 31, 251\u2013257 (2011).","journal-title":"Hamostaseologie"},{"key":"31788_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0083-6729(07)00003-9","volume":"78","author":"J Oldenburg","year":"2008","unstructured":"Oldenburg, J., Marinova, M., M\u00fcller-Reible, C. & Watzka, M. The vitamin K cycle. Vitam. Horm. 78, 35\u201362 (2008).","journal-title":"Vitam. Horm."},{"key":"31788_CR8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1160\/TH08-09-0611","volume":"101","author":"R Koos","year":"2009","unstructured":"Koos, R. et al. Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb. Haemost. 101, 706\u2013713 (2009).","journal-title":"Thromb. Haemost."},{"key":"31788_CR9","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/j.1538-7836.2009.03630.x","volume":"7","author":"RG Lerner","year":"2009","unstructured":"Lerner, R. G. et al. Warfarin use and the risk of valvular calcification. J. Thromb. Haemost. JTH 7, 2023\u20132027 (2009).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"31788_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00223-009-9300-4","volume":"85","author":"TC Villines","year":"2009","unstructured":"Villines, T. C., O\u2019Malley, P. G., Feuerstein, I. M., Thomas, S. & Taylor, A. J. Does prolonged warfarin exposure potentiate coronary calcification in humans? Results of the warfarin and coronary calcification study. Calcif. Tissue Int. 85, 494\u2013500 (2009).","journal-title":"Calcif. Tissue Int."},{"key":"31788_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/clc.20865","volume":"34","author":"C Palaniswamy","year":"2011","unstructured":"Palaniswamy, C., Sekhri, A., Aronow, W. S., Kalra, A. & Peterson, S. J. Association of warfarin use with valvular and vascular calcification: a review. Clin. Cardiol. 34, 74\u201381 (2011).","journal-title":"Clin. Cardiol."},{"key":"31788_CR12","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1093\/eurheartj\/ehr226","volume":"32","author":"B Weijs","year":"2011","unstructured":"Weijs, B. et al. Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur. Heart J. 32, 2555\u20132562 (2011).","journal-title":"Eur. Heart J."},{"key":"31788_CR13","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1182\/blood-2010-01-264598","volume":"115","author":"RJMW Rennenberg","year":"2010","unstructured":"Rennenberg, R. J. M. W. et al. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood 115, 5121\u20135123 (2010).","journal-title":"Blood"},{"key":"31788_CR14","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1182\/blood-2004-04-1277","volume":"104","author":"LJ Schurgers","year":"2004","unstructured":"Schurgers, L. J., Aebert, H., Vermeer, C., B\u00fcltmann, B. & Janzen, J. Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 104, 3231\u20133232 (2004).","journal-title":"Blood"},{"key":"31788_CR15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/01.ATV.18.9.1400","volume":"18","author":"PA Price","year":"1998","unstructured":"Price, P. A., Faus, S. A. & Williamson, M. K. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 18, 1400\u20131407 (1998).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"31788_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ki.2012.477","volume":"83","author":"KM McCabe","year":"2013","unstructured":"McCabe, K. M. et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 83, 835\u2013844 (2013).","journal-title":"Kidney Int."},{"key":"31788_CR17","doi-asserted-by":"publisher","first-page":"e43229","DOI":"10.1371\/journal.pone.0043229","volume":"7","author":"LJ Schurgers","year":"2012","unstructured":"Schurgers, L. J. et al. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PloS One 7, e43229 (2012).","journal-title":"PloS One"},{"key":"31788_CR18","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1373\/clinchem.2006.078139","volume":"53","author":"Y Zhu","year":"2007","unstructured":"Zhu, Y. et al. Estimation of warfarin maintenance dose based on VKORC1 (\u22121639 G\u2009>\u2009A) and CYP2C9 genotypes. Clin. Chem. 53, 1199\u20131205 (2007).","journal-title":"Clin. Chem."},{"key":"31788_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2006.10.021","volume":"120","author":"T Yin","year":"2007","unstructured":"Yin, T. & Miyata, T. Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives. Thromb. Res. 120, 1\u201310 (2007).","journal-title":"Thromb. Res."},{"key":"31788_CR20","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1161\/CIRCULATIONAHA.105.580167","volume":"113","author":"Y Wang","year":"2006","unstructured":"Wang, Y. et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113, 1615\u20131621 (2006).","journal-title":"Circulation"},{"key":"31788_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/FPC.0b013e32833433b6","volume":"20","author":"RP Owen","year":"2010","unstructured":"Owen, R. P., Gong, L., Sagreiya, H., Klein, T. E. & Altman, R. B. VKORC1 pharmacogenomics summary. Pharmacogenet. Genomics 20, 642\u2013644 (2010).","journal-title":"Pharmacogenet. Genomics"},{"key":"31788_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1161\/ATVBAHA.107.159913","volume":"28","author":"M Teichert","year":"2008","unstructured":"Teichert, M. et al. Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study. Arterioscler. Thromb. Vasc. Biol. 28, 771\u2013776 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"31788_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.diabres.2011.06.021","volume":"94","author":"A Tavridou","year":"2011","unstructured":"Tavridou, A. et al. Association of VKORC1 \u22121639 G\u2009>\u2009A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 94, 236\u2013241 (2011).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"31788_CR24","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1161\/ATVBAHA.114.303211","volume":"34","author":"RM Holden","year":"2014","unstructured":"Holden, R. M. et al. Sequence variation in vitamin K epoxide reductase gene is associated with survival and progressive coronary calcification in chronic kidney disease. Arterioscler. Thromb. Vasc. Biol. 34, 1591\u20131596 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"31788_CR25","first-page":"908","volume":"27","author":"NA Osman","year":"2016","unstructured":"Osman, N. A., El-Abd, N. & Nasrallah, M. VKORC1 gene (vitamin K epoxide reductase) polymorphisms are associated with cardiovascular disease in chronic kidney disease patients on hemodialysis. Saudi J. Kidney Dis. Transplant. Off. Publ. Saudi Cent. Organ Transplant. Saudi Arab. 27, 908\u2013915 (2016).","journal-title":"Saudi J. Kidney Dis. Transplant. Off. Publ. Saudi Cent. Organ Transplant. Saudi Arab."},{"key":"31788_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/gtmb.2016.0311","volume":"21","author":"D Turgut Cosan","year":"2017","unstructured":"Turgut Cosan, D. et al. Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension. Genet. Test. Mol. Biomark. 21, 292\u2013297 (2017).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"31788_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1538-7836.2010.04095.x","volume":"9","author":"M Watzka","year":"2011","unstructured":"Watzka, M. et al. Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. J. Thromb. Haemost. JTH 9, 109\u2013118 (2011).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"31788_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.artres.2008.09.002","volume":"2","author":"MH Kohn","year":"2008","unstructured":"Kohn, M. H., Price, R. E. & Pelz, H.-J. A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats. Artery Res. 2, 138\u2013147 (2008).","journal-title":"Artery Res."},{"key":"31788_CR29","first-page":"55","volume":"58","author":"M Komai","year":"1988","unstructured":"Komai, M., Shirakawa, H. & Kimura, S. Newly developed model for vitamin K deficiency in germfree mice. Int. J. Vitam. Nutr. Res. Int. Z. Vitam.- Ernahrungsforschung J. Int. Vitaminol. Nutr. 58, 55\u201359 (1988).","journal-title":"Z. Vitam.- Ernahrungsforschung J. Int. Vitaminol. Nutr."},{"key":"31788_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/iep.12178","volume":"97","author":"Y Mi","year":"2016","unstructured":"Mi, Y. et al. Establishing a rat model for the study of vitamin K deficiency. Int. J. Exp. Pathol. 97, 187\u2013193 (2016).","journal-title":"Int. J. Exp. Pathol."},{"key":"31788_CR31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/FPC.0b013e32832ee55b","volume":"19","author":"A Grandemange","year":"2009","unstructured":"Grandemange, A. et al. Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats. Pharmacogenet. Genomics 19, 742\u2013750 (2009).","journal-title":"Pharmacogenet. Genomics"},{"key":"31788_CR32","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1111\/jth.12019","volume":"10","author":"A Hodroge","year":"2012","unstructured":"Hodroge, A. et al. VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity. J. Thromb. Haemost. JTH 10, 2535\u20132543 (2012).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"31788_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.abb.2011.08.010","volume":"515","author":"A Hodroge","year":"2011","unstructured":"Hodroge, A., Longin-Sauvageon, C., Fourel, I., Benoit, E. & Lattard, V. Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants. Arch. Biochem. Biophys. 515, 14\u201320 (2011).","journal-title":"Arch. Biochem. Biophys."},{"key":"31788_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.fob.2013.02.001","volume":"3","author":"B Matagrin","year":"2013","unstructured":"Matagrin, B. et al. New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations. FEBS Open Bio 3, 144\u2013150 (2013).","journal-title":"FEBS Open Bio"},{"key":"31788_CR35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1152\/ajplegacy.1969.217.5.1316","volume":"217","author":"MA Hermodson","year":"1969","unstructured":"Hermodson, M. A., Suttie, J. W. & Link, K. P. Warfarin metabolism and vitamin K requirement in the warfarin-resistant rat. Am. J. Physiol. 217, 1316\u20131319 (1969).","journal-title":"Am. J. Physiol."},{"key":"31788_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/224284a0","volume":"224","author":"JH Greaves","year":"1969","unstructured":"Greaves, J. H. & Ayres, P. Linkages between genes for coat colour and resistance to warfarin in Rattus norvegicus. Nature 224, 284\u2013285 (1969).","journal-title":"Nature"},{"key":"31788_CR37","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/jth.12306","volume":"11","author":"J-K Tie","year":"2013","unstructured":"Tie, J.-K., Jin, D.-Y., Tie, K. & Stafford, D. W. Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells. J. Thromb. Haemost. JTH 11, 1556\u20131564 (2013).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"31788_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nsmb.3338","volume":"24","author":"KJ Czogalla","year":"2017","unstructured":"Czogalla, K. J. et al. Warfarin and vitamin K compete for binding to Phe55 in human VKOR. Nat. Struct. Mol. Biol. 24, 77\u201385 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"31788_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature02214","volume":"427","author":"S Rost","year":"2004","unstructured":"Rost, S. et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature. 427, 537\u201341 (2004).","journal-title":"Nature."},{"key":"31788_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/ki.2012.191","volume":"82","author":"ECM Cranenburg","year":"2012","unstructured":"Cranenburg, E. C. M. et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int. 82, 605\u2013610 (2012).","journal-title":"Kidney Int."},{"key":"31788_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jn\/138.3.492","volume":"138","author":"SL Booth","year":"2008","unstructured":"Booth, S. L. et al. Age and dietary form of vitamin K affect menaquinone-4 concentrations in male Fischer 344 rats. J. Nutr. 138, 492\u2013496 (2008).","journal-title":"J. Nutr."},{"key":"31788_CR42","doi-asserted-by":"publisher","first-page":"28733","DOI":"10.1074\/jbc.M113.457119","volume":"288","author":"A Hammed","year":"2013","unstructured":"Hammed, A., Matagrin, B., Spohn, G., Benoit, E. & Lattard, V. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy. J. Biol. Chem. 288, 28733\u201328742 (2013).","journal-title":"J. Biol. Chem."},{"key":"31788_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.molmed.2012.12.008","volume":"19","author":"LJ Schurgers","year":"2013","unstructured":"Schurgers, L. J., Uitto, J. & Reutelingsperger, C. P. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol. Med. 19, 217\u2013226 (2013).","journal-title":"Trends Mol. Med."},{"key":"31788_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/jn\/69.1.18","volume":"69","author":"VA Metta","year":"1959","unstructured":"Metta, V. A., Mameesh, M. S. & Johnson, B. C. Vitamin K deficiency in rats induced by the feeding of irradiated beef. J. Nutr. 69, 18\u201322 (1959).","journal-title":"J. Nutr."},{"key":"31788_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/jn\/72.4.455","volume":"72","author":"VC Metta","year":"1960","unstructured":"Metta, V. C. & Johnson, B. C. Effect of feeding vitamin K-deficient diets to female rats. J. Nutr. 72, 455\u2013458 (1960).","journal-title":"J. Nutr."},{"key":"31788_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tox.2016.02.002","volume":"344-346","author":"S Lefebvre","year":"2016","unstructured":"Lefebvre, S., Rannou, B., Besse, S., Benoit, E. & Lattard, V. Origin of the gender differences of the natural resistance to antivitamin K anticoagulants in rats. Toxicology. 344-346, 34\u201341 (2016).","journal-title":"Toxicology."},{"key":"31788_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3945\/ajcn.2009.27930","volume":"90","author":"JC McCann","year":"2009","unstructured":"McCann, J. C. & Ames, B. N. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr. 90, 889\u2013907 (2009).","journal-title":"Am J Clin Nutr."},{"key":"31788_CR48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ki.2013.530","volume":"86","author":"N Kaesler","year":"2014","unstructured":"Kaesler, N. et al. Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int. 86, 286\u2013293 (2014).","journal-title":"Kidney Int."},{"key":"31788_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1159\/000075344","volume":"40","author":"HM Spronk","year":"2003","unstructured":"Spronk, H. M. et al. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J. Vasc. Res. 40, 531\u2013537 (2003).","journal-title":"J. Vasc. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31788-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:38:29Z","timestamp":1671615509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31788-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31788"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31788-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]},"assertion":[{"value":"27 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13733"}}